Amgen, Inc. (AMGN) Issues FY14 Earnings Guidance
Amgen, Inc. (NASDAQ:AMGN) updated its FY14 earnings guidance on Tuesday. The company provided EPS guidance of $8.20-8.40 for the period, compared to the Thomson Reuters consensus EPS estimate of $8.09, Analyst Ratings.Net reports. The company issued revenue guidance of $19.5-19.7 billion, compared to the consensus revenue estimate of $19.41 billion.
A number of research firms have recently commented on AMGN. Analysts at Deutsche Bank raised their price target on shares of Amgen from $144.00 to $149.00 in a research note on Friday, July 18th. They now have a buy rating on the stock. On a related note, analysts at Morgan Stanley reiterated an overweight rating on shares of Amgen in a research note on Tuesday, June 10th. They now have a $140.00 price target on the stock. Finally, analysts at Morgan Stanley reiterated an overweight rating on shares of Amgen in a research note on Monday, May 12th. They now have a $140.00 price target on the stock. Six research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the company’s stock. The company presently has a consensus rating of Buy and a consensus price target of $133.44.
Shares of Amgen, Inc. (NASDAQ:AMGN) traded up 0.54% on Tuesday, hitting $123.31. 3,881,634 shares of the company’s stock traded hands. Amgen, Inc. has a one year low of $103.31 and a one year high of $128.96. The stock’s 50-day moving average is $118.9 and its 200-day moving average is $118.8. The company has a market cap of $93.348 billion and a P/E ratio of 19.91.
Amgen (NASDAQ:AMGN) last issued its quarterly earnings data on Tuesday, July 29th. The company reported $2.37 EPS for the quarter, beating the Thomson Reuters consensus estimate of $2.07 by $0.30. The company had revenue of $5.18 billion for the quarter, compared to the consensus estimate of $4.90 billion. During the same quarter in the prior year, the company posted $1.89 earnings per share. The company’s quarterly revenue was up 10.7% on a year-over-year basis. On average, analysts predict that Amgen, Inc. will post $8.09 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Friday, September 5th. Investors of record on Thursday, August 14th will be paid a dividend of $0.61 per share. This represents a $2.44 annualized dividend and a dividend yield of 1.98%. The ex-dividend date is Tuesday, August 12th.
Amgen Inc is a global biotechnology pioneer that discovers, develops, manufactures and delivers human therapeutics.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.